Prednisolone Acetate/Sulfacetamide Sodium

醋酸泼尼松龙/磺胺醋酰钠

Report date: 2022/09/29 20:01:43

Base Information

Drug NamePrednisolone Acetate/Sulfacetamide Sodium

Drug Alias NamePrednisolone Acetate aand Sulfacetamide SodiumSulfacetamide Sodium and Prednisolone Acetatesulfacetamide sodium–prednisolone acetateSulfacetamide and prednisoloneSulfacetamide Sodium/Prednisolone Acetate +[6]

ClassificationSmall molecules > Steroids

Mechanisms of ActionDihydropteroate synthase inhibitors

TargetsDihydropteroate synthase

Therapy Area/IndicationsEye Infections

Global Approved IndicationsEye Infections

Approved Indications in ChinaN/A

Original Approved Country/TerritoryUnited States

Original Approved Date1961/09/18

Country/TerritoryUnited States

CombinationsYes Sulfacetamide Sodium

Global Highest StatusWithdrawn

Highest Status in ChinaN/A

Originator CompaniesAllergan Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAllergan Plc

Active IndicationsN/A

Inactive IndicationsEye Infections

Other Information

ATC CodeR01AD52